The deal came on the same day that Ivax
reported losing $179 million, or $1.
Giorgio D'Urso, CEO and president of IVAX
Diagnostics, also stated, "We previously indicated that we expected to receive 510(k) clearance from the FDA during 2006.
In Europe, IVAX
subsidiaries include IVAX
Pharmaceuticals UK, which develops, manufactures and sells branded and generic products in the United Kingdom, Ireland and other countries, and IVAX
Pharmaceuticals SRO in the Czech Republic, which develops, manufactures and markets pharmaceuticals, mainly to the Eastern European market.
is offering to purchase the Notes for cash at a purchase price, per $1,000 principal amount, equal to 100% of the principal amount, together with $17.
Pursuant to the merger agreement between the parties, Ivax
shareholders had the right to elect to receive for each Ivax
share they owned either 0.
Corporation, headquartered in Miami, Florida, discovers, develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products in the U.
shareholders are advised that, given a scheduled closing date of January 26, 2006, the election deadline for making a cash or stock election under the merger agreement will be 5:00 p.
Teva and IVAX
will promptly announce the acceptance by the FTC of the consent order upon its receipt, and will schedule the closing for the third business day following such announcement.
With Teva's approval, IVAX
has declined to elect the "public acquirer fundamental change" option with respect to such notes.
Teva and IVAX
are continuing to work closely with the U.
Documents filed with the SEC may be obtained without charge at IVAX
Corporation's website, http://www.
Pursuant to the provisions of the applicable indentures, IVAX
will provide at least 15 days notice of the anticipated closing date of the merger.